Effect of Bronchofibroscope in the prevention and treatment for ventilator associated pneumonia in ICU patients combined with respiratory muscle
1|1
Department of Intensive Care Unit ; the first affiliated hospital of Nanchang university; Nanchang City; Jiangxi Province; China
Objective Summarize the application of bronchofibroscope in the prevention and treatment for ventilator-associated pneumonia in ICU patients with respiratory muscle weakness, and evaluate its therapeutic effect.
Methods Thirty-nine patients with respiratory muscle weakness such as myasthenia gravis crisis, high paraplegia, severe acute Guillain-Barre syndrome, acute myelitis were randomly divided into treatment or control groups, treatment group 20 cases, with conventional treatment and early using bronchofibroscope to suction, lavage. The control group, nineteenth cases with conventional treatment. The incidence of ventilator-associated pneumonia and arterial blood gas analysis were observed and compared in the two groups.
Results The result of arterial blood gas analysis in treatment group showed significant improvement for half an hour after bronchofibroscope treatment, in the control group, there was no significant change in arterial blood gas analysis. The incidence of ventilator-associated pneumonia in Treatment group was 25%, and the incidence of ventilator-associated pneumonia in control group was 57.9%. The incidence of ventilator-associated pneumonia in control group was significantly higher than the treatment group (P <0.01).
Conclusion Bronchofibroscope can play a positive, effective and safe role in the treatment for ventilator-associated pneumonia in ICU patients with respiratory muscle weakness, and can effectively reduce the incidence of ventilator-associated pneumonia.
Methods Thirty-nine patients with respiratory muscle weakness such as myasthenia gravis crisis, high paraplegia, severe acute Guillain-Barre syndrome, acute myelitis were randomly divided into treatment or control groups, treatment group 20 cases, with conventional treatment and early using bronchofibroscope to suction, lavage. The control group, nineteenth cases with conventional treatment. The incidence of ventilator-associated pneumonia and arterial blood gas analysis were observed and compared in the two groups.
Results The result of arterial blood gas analysis in treatment group showed significant improvement for half an hour after bronchofibroscope treatment, in the control group, there was no significant change in arterial blood gas analysis. The incidence of ventilator-associated pneumonia in Treatment group was 25%, and the incidence of ventilator-associated pneumonia in control group was 57.9%. The incidence of ventilator-associated pneumonia in control group was significantly higher than the treatment group (P <0.01).
Conclusion Bronchofibroscope can play a positive, effective and safe role in the treatment for ventilator-associated pneumonia in ICU patients with respiratory muscle weakness, and can effectively reduce the incidence of ventilator-associated pneumonia.
